Transnasal humidified rapid insufflation ventilatory exchange versus conventional facemask breathing for preoxygenation during anesthesia induction in TBI surgery: a randomized controlled trial Authors: Xiaoping Chen, Chen Yang, Yue Zhao, Ju Gao, Yali Ge, Yang Zhang Published: 2025 ABSTRACT ObjectiveTo assess the effect of transnasal humidified rapid insufflation ventilatory exchange (THRIVE) on regional cerebral oxygen saturation (rScO2) during general anesthesia induction in traumatic brain injury (TBI) emergency surgery.MethodsIn this prospective randomized trial, 63 TBI patients undergoing emergency intracranial hematoma removal were allocated to conventional mask ventilation group (n = 32; 8 L/min O2, FiO2 1.00) or THRIVE group (n = 31; 30–50 L/min O2, FiO2 1.00). Outcomes included rScO2, PaO2, PaCO2, hypoxemia incidence (SpO2 < 95%), end-tidal CO2 (PETCO2), and Glasgow Outcome Scale (GOS) at discharge.ResultsAfter 10-min preoxygenation, the THRIVE group exhibited higher rScO2 (surgical side: 70.9% ± 3.6% vs. 63.6% ± 2.8%; non-surgical: 79.1% ± 1.6% vs. 71.2% ± 2.7%; P < 0.01), increased PaO2 (450.23 ± 60.99 vs. 264.88 ± 49.33 mmHg), and reduced PaCO2 (37.81 ± 3.65 vs. 43.59 ± 3.76 mmHg; P < 0.01). During tracheal intubation, hypoxemia events, defined as SpO2 < 95%, occurred in 0/31 patients (0%) in the THRIVE group versus 9/32 patients (28.1%) in the conventional ventilation group (P < 0.01). PETCO2 post-intubation was lower in the THRIVE group (43.10 ± 2.66 vs. 49.22 ± 3.31 mmHg; P < 0.01). Patients receiving THRIVE had a higher proportion of good neurological outcomes (GOS > 3: 35.5% vs. P < 0.05). ICU/hospital stay and gastric antrum cross-sectional area showed no intergroup differences.ConclusionTHRIVE could significantly increase rScO2 during anesthesia induction in TBI emergency surgery patients and improve their neurological functional prognosis.Trial registration retrospectively registered; Chinese Clinical Trial Registry, www.chictr.org.cn, number ChiCTR 2300073951: Registered on June 26.2023. Introduction Traumatic brain injury (TBI) is one of the most prevalent diseases seriously endangering human health with high disability and mortality. Hence, patients often require prolonged medical care and rehabilitation, imposing a great social and economic burden [1]. TBI can cause both primary and secondary brain injury. Primary injury mainly involves direct damage to brain tissue caused by an impact. Furthermore, the ensuing acute systemic damage further aggravates the injury. Brain tissues and neuronal cells develop various responses to TBI, including inflammation, excitatory neurotransmitter release, oxidative stress, and vascular and mitochondrial dysfunction, which stimulate energy metabolism in the brain, increase oxygen consumption, and decrease cerebral blood flow. All these responses further aggravate brain ischemia and hypoxia through secondary brain injury [2]. Nowadays, ischemia and hypoxia represent common independent risk factors for neurological deterioration after craniocerebral injury [3, 4]. Thus, anesthesiologists must take targeted measures to prevent hypoxia perioperatively. For instance, early airway management is a key component in preventing hypoxia. For patients with Glasgow Coma Score (GCS) ≤ 8, timely tracheal intubation is recommended to ensure oxygenation while avoiding hypercapnia-induced increased intracranial pressure (ICP; target PaCO2: 35–45 mmHg) [5]. In patients with moderate-to-severe TBI, both hypoxemia and extreme hyperoxemia were associated with increased mortality; therefore, hyperoxygen therapy (PaO2 > 300 mmHg) may exacerbate the damage from oxidative stress [6]. Using regional brain oxygen saturation (rSO2) to monitor the noninvasiveness of brain tissue oxygen supply and assessing the balance by near-infrared spectroscopy (NIRS) are important in the individualized management of TBI patients. Studies showed that patients with TBI are prone to occult cerebral ischemia due to the dysregulation of cerebral blood flow, elevated ICP, or microcirculation failure. Additionally, rSO2 can reflect the status of cerebral oxygen metabolism in real time. Clinical data confirm that rSO2 < 60% is significantly associated with secondary brain injury (e.g., cerebral infarction and cerebral edema progression) and poor neurological outcomes [7]. Therefore, maintaining high rScO2 perioperatively may benefit patients with TBI, thereby improving their prognosis. Furthermore, patients with TBI often suffer from preoperative hypoxemia, and preoxygenation without positive-pressure ventilation during the conventional induction of anesthesia further increases the risk of cerebral hypoxia in such patients. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) can deliver a high flow of warmed, humidified gas with an oxygen concentration of 21%–100% at a temperature of 31–37 ℃ over a short period [8]. THRIVE has a continuous flushing effect on the upper airway, which reduces physiological dead space, increases the fraction of inspired oxygen (FiO₂), and improves oxygenation [5, 9]. In previous studies of TBI patients with mild-to-moderate respiratory failure who did not require emergency intubation in the intensive care unit, THRIVE effectively improved oxygenation (PaO₂/FiO₂) and reduced the work of breathing, and was considered a potential treatment of choice in head trauma or brain surgery patients under appropriate monitoring [10]. Studies have also demonstrated that the positive end-expiratory pressure effect (approximately 2–5 cmH₂O) generated by THRIVE helps maintain alveolar recruitment and reduce the incidence of atelectasis, thereby decreasing secondary brain injury caused by hypoxemia [11]. In addition, the high-flow “scouring” effect of THRIVE can reduce anatomical dead space, promote CO₂ elimination, and may help regulate PaCO₂ in TBI patients with hypercapnia. However, THRIVE has rarely been used during anesthesia induction in TBI patients. Our previous study showed that THRIVE preoxygenation can significantly prolong the duration of safe apnea while maintaining oxygenation without the need for positive-pressure ventilation [12]. However, whether THRIVE can be safely applied during the induction of anesthesia in patients with TBI, and whether it can improve regional cerebral oxygen saturation (rScO₂) and postoperative recovery, has not been reported. Therefore, this study aimed to evaluate the effect of THRIVE on rScO₂ during induction of general anesthesia in patients with TBI undergoing emergency neurosurgery. Patients and methods Study approval and registration The study complied with medical ethics standards and was approved by the Medical Ethics Committee of the Northern Jiangsu People’s Hospital on December 30, 2022 (approval No. 2022ky363-1) and registered in the China Clinical Trial Registry (registration no. ChiCTR 2300073951). The families of the participating cases were fully aware of the contents of the study and signed an informed consent form. Patients A prospective randomized controlled study was conducted in our hospital from August 2023 to February 2024. Adult patients with traumatic brain injury who were scheduled to undergo emergency general anesthesia and intracranial hematoma evacuation were enrolled as study subjects. All enrolled patients arrived in the operating room breathing spontaneously with a patent airway; patients who required emergency endotracheal intubation before arrival in the operating room were excluded. Inclusion criteria comprised (1) age > 18 years old; (2) normal spontaneous respiration and clear airway; (3) closed traumatic brain injury; and (4) intact forehead skin. Exclusion criteria were (1) American Society of Anesthesiologists (ASA) classification of > IV grade; (2) bilateral pupil dilatation, advanced brain herniation, and brainstem failure; (3) previous history of craniocerebral surgery or intracranial large artery vascularization and intracranial tumors; (4) previous nasal mucous membrane lesions and nasal surgery, trauma; (5) previous esophageal lesions and gastric surgery; (6) admission to the operating room with an endotracheal tube. Furthermore, removal criteria included (1) treatment abandonment or death in the middle of the study; (2) inability to cooperate with closed-mouth breathing; (3) poor acquisition of ultrasound images of the gastric sinus. Methods The patients were divided into conventional mask ventilation and THRIVE groups using a randomized numerical table. In both groups, family members were routinely asked about the duration of fasting, and the Glasgow Coma Scale (GCS) was assessed preoperatively. All enrolled patients had moderate-to-severe TBI (GCS 3–12); no patient with mild TBI (GCS > 12) was included. The distribution of GCS scores is shown in Table 1. After the patients entered the operating room, the peripheral venous access was opened. Then, a monitor was connected to monitor heart rate (HR), mean artery pressure (MAP), and pulse oxygen saturation (SpO2), whereas the optic nerve sheath diameter (ONSD) was measured by ultrasound. Additionally, radial artery puncture pressure was measured under local anesthesia. All included patients were intubated in the operating room after induction of general anesthesia. Patients who had been intubated in the field or in the emergency department before arrival in the operating room were excluded. Table 1Comparison of baseline data and surgical conditions of emergency general anesthesia surgery patients with TBI in the two groups with different ventilation modalitiesConventional mask ventilation group (n = 32)THRIVE group (n = 31)χ2/Z/tpGender0.1760.979 Male1920 Female1311Age (years)60.0 (47.5, 70.0)65.0 (53.0, 71.0)−0.7980.425BMI (kg/m2)24.06 ± 1.8624.22 ± 1.930.3370.737ASA0.2530.672 Ⅲ23 Ⅳ3028GSC0.190.793 13–1500 9–121210 3–82021ONSD (mm)6.02 ± 0.166.04 ± 0.18−0.6210.537HR (bpm/min)88.50 ± 9.4188.81 ± 8.340.1370.892MAP (mmHg)99.59 ± 13.49104.48 ± 13.001.4640.148SpO20.9 (0.90, 0.94)0.93 (0.92, 0.94)−0.9090.363Fasted0.3840.613 Yes12 No3129Anesthesia duration(min)242.81 ± 26.43246.13 ± 21.860.5420.59Surgery duration(min)193.13 ± 27.41196.45 ± 23.030.5210.604Intraoperative blood loss225 (200, 250)200 (200, 250)−0.2940.355THRIVE: Transnasal humidified rapid inflation exchange ventilation; TBI: Traumatic brain injury; BMI: Body mass index; ASA: American Society of Anesthesiologists; GCS: Glasgow Coma Score; ONSD: Optic nerve sheath diameter; HR: Heart rate; MAP: Mean arterial pressure; SpO2: Pulse oximetry; 1 mmHg ≈ 0.133 kPa Table 1Comparison of baseline data and surgical conditions of emergency general anesthesia surgery patients with TBI in the two groups with different ventilation modalitiesConventional mask ventilation group (n = 32)THRIVE group (n = 31)χ2/Z/tpGender0.1760.979 Male1920 Female1311Age (years)60.0 (47.5, 70.0)65.0 (53.0, 71.0)−0.7980.425BMI (kg/m2)24.06 ± 1.8624.22 ± 1.930.3370.737ASA0.2530.672 Ⅲ23 Ⅳ3028GSC0.190.793 13–1500 9–121210 3–82021ONSD (mm)6.02 ± 0.166.04 ± 0.18−0.6210.537HR (bpm/min)88.50 ± 9.4188.81 ± 8.340.1370.892MAP (mmHg)99.59 ± 13.49104.48 ± 13.001.4640.148SpO20.9 (0.90, 0.94)0.93 (0.92, 0.94)−0.9090.363Fasted0.3840.613 Yes12 No3129Anesthesia duration(min)242.81 ± 26.43246.13 ± 21.860.5420.59Surgery duration(min)193.13 ± 27.41196.45 ± 23.030.5210.604Intraoperative blood loss225 (200, 250)200 (200, 250)−0.2940.355THRIVE: Transnasal humidified rapid inflation exchange ventilation; TBI: Traumatic brain injury; BMI: Body mass index; ASA: American Society of Anesthesiologists; GCS: Glasgow Coma Score; ONSD: Optic nerve sheath diameter; HR: Heart rate; MAP: Mean arterial pressure; SpO2: Pulse oximetry; 1 mmHg ≈ 0.133 kPa Comparison of baseline data and surgical conditions of emergency general anesthesia surgery patients with TBI in the two groups with different ventilation modalities THRIVE: Transnasal humidified rapid inflation exchange ventilation; TBI: Traumatic brain injury; BMI: Body mass index; ASA: American Society of Anesthesiologists; GCS: Glasgow Coma Score; ONSD: Optic nerve sheath diameter; HR: Heart rate; MAP: Mean arterial pressure; SpO2: Pulse oximetry; 1 mmHg ≈ 0.133 kPa Each patient was placed in the supine position with the head of the bed elevated by 30°. All patients underwent a modified rapid-sequence induction without mask positive-pressure ventilation in order to minimize the risk of pulmonary aspiration. In the conventional mask ventilation group, preoxygenation was performed for 10 min with a facemask at an oxygen flow of 8 L/min and an FiO₂ of 1.00. Anesthesia was then induced with intravenous sufentanil 0.5 μg/kg, propofol 0.5–1.0 mg/kg, and rocuronium bromide 0.6 mg/kg, and tracheal intubation was performed as soon as adequate neuromuscular relaxation was achieved (approximately 60–90 s). In the THRIVE group, preoxygenation was delivered with THRIVE for 10 min at a flow rate of 30 L/min and an FiO₂ of 1.00; during induction and the apneic period, the THRIVE flow was increased to 50 L/min. The medications and doses used for induction were the same as in the conventional mask ventilation group. After induction, a two-handed jaw-thrust maneuver was applied to maintain airway patency while keeping the patient’s mouth closed throughout the apneic period until laryngoscopy and tracheal intubation were completed. Following tracheal intubation, the ventilator was connected for mechanical ventilation, and the partial pressure of end-tidal carbon dioxide (PETCO2) was recorded during the first mechanical ventilation. Ventilation parameters were tidal volume of 6–8 mL/kg, ventilation rate of 14 breaths/min, inspiratory/expiratory ratio of 1:2, and intraoperative PETCO2 of 35–45 mmHg (1 mmHg ≈ 0.133 kPa). Intraoperative anesthesia was maintained using a combined intravenous–inhalational technique, including continuous remifentanil infusion (e.g., 0.1–0.25 μg·kg⁻1·min⁻1) and sevoflurane (approximately 1.0–2.0 vol%) in an oxygen–air mixture, with additional rocuronium as needed. Doses were titrated to maintain heart rate and mean arterial pressure within ± 20% of baseline. Vasoactive agents (e.g., norepinephrine, ephedrine, atropine) were administered if necessary. The anesthesia provider had no prior knowledge of the study protocol, and anesthesia management was performed by different anesthesiologists on duty. The random allocation sequence was generated by an independent statistician using a computer-generated random number table. Group assignments were placed in sealed, opaque envelopes to ensure allocation concealment. The anesthesiologists performing the preoxygenation and induction were not blinded to the group assignment due to the nature of the intervention. However, the staff responsible for outcome assessments (including rScO₂ measurements, arterial blood gas analysis, and gastric ultrasound) were blinded to the group allocation. Observational indicators and methods rScO2 rScO2 was recorded at admission to the operating room (T1), 10 min of preoxygenation (T2), and at successful intubation (T3) on the patient’s operative and non-operative sides. rScO2 was measured by placing the sensor probes of the cerebral oxygen monitors on the anterior edge of the frontal area hairline of each side at a distance of 1–2 cm from the arch of the eyebrow after the patient had been placed in a flat position, followed by skin disinfection with 75% ethanol [5, 9]. ONSD The patient was placed in the supine position, both eyes were closed, and the ONSD was measured by ultrasound. A transparent patch was placed over the eyelids, and gel was applied. The ONSD was measured 3 mm behind the optic discs using a line array probe with a frequency of 5–10 MHz at an appropriate angle. Three ONSD measurements were performed in the transverse and sagittal planes of both eyes [13] on each side, recording the average value. ONSD was measured 3 mm behind the globe as previously described; values above approximately 5.0–5.7 mm are considered consistent with elevated intracranial pressure in adults. In this study, ONSD was used to trend potential changes in ICP during preoxygenation rather than for diagnostic classification. Cross-sectional area The cross-sectional area (CSA) was measured by ultrasound at admission to the operating room, 10 min of preoxygenation, and at successful intubation. The CSA was measured by the same surgeon trained in this field. The patient was placed in the supine position with the head of the bed elevated at 45°, and a Huasheng ultrasound machine with a 2–5 MHz low-frequency probe was used on the right side of the patient's upper abdomen. The ultrasound probe was placed under the xiphoid process, slightly to the right of the midline, with the probe marking point directed toward the head. The gastric sinusoids were marked by the abdominal aorta and the left lobe of the liver, which were located in the triangle formed by the liver and the abdominal aorta. The intervals of gastric peristaltic movements were measured to obtain a standardized scanning level. The CSA was measured directly by the tracing method, with three measurements being averaged to reduce the measurement error. A comet tail shadow observed under ultrasound is a sign of gastric insufflation [14, 15]. PaO₂ and PaCO₂ Measure PaO₂ and PaCO₂ 10 min after preoxygenation in the operating room, and immediately take radial artery blood for arterial blood gas analysis after successful intubation. Adverse effects The occurrence of hypoxemia (SpO2 < 0.95%) during tracheal intubation of patients was recorded. Prognostic indicators The length of intensive care unit (ICU) stay, the hospitalization length, and the Glasgow outcome scale (GOS) at discharge were recorded. Statistical analysis Based on the results of the pre-test, the sample size was calculated using the PASS 11.0 software, setting bilateral α at 0.05 and 1 − β at 0.8. Thus, a sample size of 58 subjects was estimated for this study. Considering a sample dropout rate of about 20%, the final total sample size for this study was 70 subjects (35 subjects in each group). The SPSS 25.0 software was used for statistical analysis. Measures with normal distribution were expressed as mean ± standard deviation (x ± SD), and two independent sample t-test was used for comparison between groups. Measures with skewed distribution were expressed as median (quartile) [median (1Q, 3Q)]), and the Mann–Whitney U-test was used for comparison between groups. Count data were expressed as frequency (percentage), and the χ2 test was used for comparison between groups. p < 0.05 indicated statistical significance. Results Patient enrollment and demographics During the study, 70 patients with TBI underwent emergency general anesthesia, of which 2 patients died after surgery, 2 patients could not cooperate with closed-mouth breathing, and 3 patients had poor ultrasound image acquisition of the gastric sinus area; thus, they were all excluded from the study. Sixty-three patients were included in the analysis, of which 32 received conventional mask ventilation and 31 received THRIVE (Fig. 1). The differences between the baseline data and surgical conditions of the two groups were not statistically significant (all p > 0.05; Table 1) but comparable. All patients included underwent the same surgical procedure: intracranial hematoma evacuation. There was no significant difference in operative time.Fig. 1Flow diagram for the present study Flow diagram for the present study rScO2 The differences in rScO2 between the operative and non-operative sides of the two groups were not statistically significant when the patients were admitted to the operating room. With the prolongation of time, rScO2 of the operative and non-operative sides in the conventional mask ventilation group showed a decreasing trend after reaching the peak value at 10 min of preoxygenation; while rScO2 of the operative and non-operative sides in the THRIVE group continued to increase, and the rScO2 of the operative and non-operative sides were significantly higher than that of the conventional mask ventilation group at the 10 min of preoxygenation and the immediate moment of successful intubation (Fig. 2.A and B).Fig. 2rScO2 between the operative and non-operative sides of the two groups. A and B Comparison of changes in rScO2 between operative and non-operative sides at different time points in emergency general anesthesia surgery patients with TBI in two groups with different ventilation modes (x ± SD). rScO2 is local cerebral oxygen saturation rScO2 between the operative and non-operative sides of the two groups. A and B Comparison of changes in rScO2 between operative and non-operative sides at different time points in emergency general anesthesia surgery patients with TBI in two groups with different ventilation modes (x ± SD). rScO2 is local cerebral oxygen saturation Arterial blood gas analysis The differences in PaO2 and PaCO2 between the two groups were not statistically significant at the time of admission to the operating room; compared with the conventional mask ventilation group, the PaO2 of patients in the THRIVE group increased significantly after 10 min of oxygen pre-inflation and successful intubation, and the PaCO2 decreased significantly (Fig. 3.A and B).Fig. 3PaO2 and PaCO2 between the two groups. A and B Comparison of the changes of arterial blood gas analysis indexes at different time points between two groups of TBI emergency general anesthesia surgery patients with different ventilation modes (x ± SD), PaO2 is arterial oxygen partial pressure, and PaCO2 is arterial carbon dioxide partial pressure; 1 mmHg≈0.133 kPa PaO2 and PaCO2 between the two groups. A and B Comparison of the changes of arterial blood gas analysis indexes at different time points between two groups of TBI emergency general anesthesia surgery patients with different ventilation modes (x ± SD), PaO2 is arterial oxygen partial pressure, and PaCO2 is arterial carbon dioxide partial pressure; 1 mmHg≈0.133 kPa PETCO2 at the time of first mechanical ventilation PETCO2 at the time of first mechanical ventilation after successful tracheal intubation in the THRIVE group was significantly lower than that in the conventional mask ventilation group (mmHg: 43.10 ± 2.66 compared to 49.22 ± 3.31, t = 8.074, P < 0.001). CSA There were no significant fluctuations in CSA during the induction period of anesthesia in both groups; the differences in CSA between the two groups were not statistically significant at the time of admission to the operating room, 10 min of preoxygenation, and the immediate moment of successful intubation (Fig. 4).Fig. 4CSA during the induction period of anesthesia in both groups. Comparison of changes in CSA at different time points between two groups of TBI emergency general anesthesia surgery patients with different ventilation modalities [median (1Q, 3Q)]. CSA is cross-sectional area of gastric sinus CSA during the induction period of anesthesia in both groups. Comparison of changes in CSA at different time points between two groups of TBI emergency general anesthesia surgery patients with different ventilation modalities [median (1Q, 3Q)]. CSA is cross-sectional area of gastric sinus Adverse effects The incidence of hypoxemia during tracheal intubation, defined as SpO2 < 95%, was significantly lower in the THRIVE group compared with the conventional mask group (0% [0/31] vs. 28.1% [9/32], χ2 = 10.172, P = 0.001). Prognostic indicators The differences in the length of ICU stay and hospitalization between the two groups were not statistically significant (all p > 0.05). However, the proportion of patients with a good prognosis at discharge was significantly higher in the THRIVE group than in the conventional mask ventilation group (p < 0.05; Table 2). Table 2Comparison of prognostic indicators of TBI emergency surgery general anesthesia patients in the two groups with different ventilation modesConventional mask ventilation group (n = 32)THRIVE group (n = 31)Χ2/Z/tpICU length of stay (d, median (1Q, 3Q))10 (9, 10)10 (9, 11)−1.1120.266Total hospitalization time (d, median (1Q, 3Q))28.00 (26.00, 28.75)28.00 (26.00, 28.75)−0.6830.495Prognosis at hospital discharge (cases [%])4.5850.041Good prognosis4 (12.5)11 (35.5)Adverse prognosis28 (87.5)20 (64.5)Glasgow Outcome Score (GOS) > 3 at discharge is defined as a good prognosis and ≤ 3 is defined as an adverse oneTHRIVE: Transnasal humidified rapid inflatable exchange ventilation; TBI: Traumatic brain injury; ICU: Intensive care unit Table 2Comparison of prognostic indicators of TBI emergency surgery general anesthesia patients in the two groups with different ventilation modesConventional mask ventilation group (n = 32)THRIVE group (n = 31)Χ2/Z/tpICU length of stay (d, median (1Q, 3Q))10 (9, 10)10 (9, 11)−1.1120.266Total hospitalization time (d, median (1Q, 3Q))28.00 (26.00, 28.75)28.00 (26.00, 28.75)−0.6830.495Prognosis at hospital discharge (cases [%])4.5850.041Good prognosis4 (12.5)11 (35.5)Adverse prognosis28 (87.5)20 (64.5)Glasgow Outcome Score (GOS) > 3 at discharge is defined as a good prognosis and ≤ 3 is defined as an adverse oneTHRIVE: Transnasal humidified rapid inflatable exchange ventilation; TBI: Traumatic brain injury; ICU: Intensive care unit Comparison of prognostic indicators of TBI emergency surgery general anesthesia patients in the two groups with different ventilation modes Glasgow Outcome Score (GOS) > 3 at discharge is defined as a good prognosis and ≤ 3 is defined as an adverse one THRIVE: Transnasal humidified rapid inflatable exchange ventilation; TBI: Traumatic brain injury; ICU: Intensive care unit Discussion Studies showed that the energy metabolism in the body is disturbed after acute TBI, which can cause different degrees of ischemia and hypoxia, as well as degeneration and necrosis of brain tissues [16]. Combined with difficulties in airway functioning, the patient's condition will deteriorate rapidly once hypoxemia and/or hypercapnia occurs [17], which will further aggravate the neurological damage. Near-infrared spectroscopy is a non-invasive method assessing the oxygenation status of local brain tissues. rScO2 is a method reflecting the balance between oxygen supply and oxygen consumption in the brain, which can effectively monitor the oxygenation status of post-TBI brain tissues [18, 19] and has important clinical significance for assessing brain metabolism after TBI. Furthermore, higher rScO2 has a stronger correlation with patient prognosis after TBI secondary injury [20]. rScO2 is significantly positively correlated with the GOS score in ICU patients [21]. GOS score, in turn, is an indicator evaluating the prognosis of a patient’s neurological function [22]. Meanwhile, some studies demonstrated that insufficient cerebral oxygenation is closely related to poor patient prognosis after brain injury [23]. However, the traditional rapid sequential induction of anesthesia without positive-pressure ventilation does not adequately ensure oxygen supply for emergency patients, further increasing the risk of insufficient cerebral oxygenation in patients with TBI. Some studies showed that THRIVE can provide heated and humidified gas with a flow rate of up to 70 L/min, which can stabilize the FiO2 of patients and reduce the anatomical dead space in the upper airway, thereby increasing the oxygen concentration in the patient’s airway and effectively improving their oxygenation [5, 9]. Lodenius et al. [24] conducted a prospective randomized controlled trial comparing the effects of THRIVE and mask preoxygenation on the minimum SpO2 during the induction of anesthesia in 80 patients undergoing emergency surgery. They showed no hypoxemia in THRIVE-treated patients, but 12.5% of the patients who were preoxygenated by mask preoxygenation had hypoxemia. Additionally, no gastric reflux occurred in either group. Nay et al. [25] conducted a multicenter, randomized controlled trial of 379 patients at risk of hypoxemia, comparing standard oxygen (8 L/min) with high-flow transnasal oxygen (70 L/min, FiO2 = 0.50%) in painless gastrointestinal endoscopy under deep sedation. According to the results, transnasal high-flow oxygen therapy significantly reduced the incidence of hypoxemia compared with standard oxygen when patients at risk of hypoxemia underwent gastrointestinal endoscopy under deep sedation. The results of this study showed that THRIVE significantly improved rScO2 during the induction of anesthesia in patients with TBI compared with conventional no-positive-pressure ventilation preoxygenation. The improvement in rScO2 on the operative side was more substantial than that on the non-operative side. Despite no statistically significant difference in the duration of ICU stay and hospitalization between the two groups, patients in the THRIVE group had a higher GOS score at discharge. It should be noted, however, that GOS is influenced by numerous perioperative and patient-related factors beyond the preoxygenation method. Therefore, while our findings suggest a potential association between improved intraoperative oxygenation and better short-term neurological outcomes, they should be interpreted as exploratory and hypothesis-generating rather than establishing a direct causal link. Therefore, preoxygenation with THRIVE during the induction of anesthesia in patients with TBI can significantly improve rScO2 and neurological prognosis. The results of arterial blood gas analysis in this study also showed that preoxygenation with THRIVE could significantly improve PaO2. Additionally, the occurrence of hypoxic events during this period was further decreased. In conclusion, our study shows that THRIVE can effectively ensure oxygenation in emergency TBI patients and further improve patient safety during the induction of anesthesia. The beneficial effects of THRIVE on cerebral oxygenation in TBI patients can be attributed to several mechanisms. First, the high-flow oxygen delivery reduces anatomical dead space and improves alveolar recruitment, thereby increasing PaO₂ and oxygen delivery to the brain. Second, the efficient CO₂ clearance observed in our study (lower PETCO₂ and PaCO₂ in the THRIVE group) is particularly critical in TBI, where hypercapnia can lead to cerebral vasodilation and increased intracranial pressure. By promoting CO₂ washout from the upper airway, THRIVE may help maintain PaCO₂ within a narrow target range, thus supporting ICP management. Additionally, the positive end-expiratory pressure (PEEP)-like effect of THRIVE helps prevent atelectasis and improves ventilation–perfusion matching, further supporting systemic and cerebral oxygenation. [25, 26]. Most patients undergoing emergency TBI are unconscious and have their stomach filled to varying degrees, which greatly increases the risk of reflux aspiration during anesthesia. As aspiration during anesthesia often occurs in patients with high intragastric pressure, the possibility that high-flow oxygen delivered through the nose may increase the risk of reflux aspiration by increasing airway pressure and causing gastric distension represents an important concern. Studies showed that the nature of gastric contents can be visualized by gastric ultrasonography, and the volume of gastric contents is significantly positively correlated with the CSA [15, 27]. Therefore, the present study performed CSA measurements at the same body surface position in both groups to evaluate the volume of gastric contents and distension. According to the results, as with conventional mask ventilation, the CSA of THRIVE did not change significantly at all time points, and the comet sign of gastric insufflation was not observed, indicating that applying THRIVE for preoxygenation during the induction of general anesthesia did not cause gastric intake in the study. This was consistent with the results of McLellan et al [28], which indicated that using THRIVE for preoxygenation during general anesthesia did not result in gastric intake. This study has several limitations. First, the study population included in the study was an emergency TBI population. Furthermore, the patients' preoperative hypoxia time, cerebral infarction area, and preoperative pulmonary function could not be absolutely homogenized. Second, rScO2 could only be monitored during the induction of anesthesia and could not be monitored during surgery in the sterilized area. Third, although we used ONSD as a non-invasive indicator of intracranial pressure, we were unable to systematically collect data on intracranial hematoma volume or midline shift due to the emergency setting. Future studies incorporating standardized preoperative imaging assessments would be valuable. Finally, the utility of THRIVE in anesthesia induction, especially with different oxygen flow rates and the duration of oxygen inhalation, needs to be further explored. In conclusion, THRIVE can be safely applied to preoxygenation during the induction of general anesthesia in patients with emergency TBI, increasing PaO2 and improving rScO2 and neurological prognosis while not influencing the incidence of gastric intake. What is known Preoxygenation is critical in TBI patients to prevent hypoxia and secondary brain injury, but conventional mask ventilation without positive-pressure ventilation may not fully ensure adequate oxygenation.THRIVE has been shown to improve oxygenation in other clinical settings by reducing anatomical dead space and maintaining FiO₂, but its application during anesthesia induction in TBI patients was previously unexplored. Preoxygenation is critical in TBI patients to prevent hypoxia and secondary brain injury, but conventional mask ventilation without positive-pressure ventilation may not fully ensure adequate oxygenation. Preoxygenation is critical in TBI patients to prevent hypoxia and secondary brain injury, but conventional mask ventilation without positive-pressure ventilation may not fully ensure adequate oxygenation. THRIVE has been shown to improve oxygenation in other clinical settings by reducing anatomical dead space and maintaining FiO₂, but its application during anesthesia induction in TBI patients was previously unexplored. THRIVE has been shown to improve oxygenation in other clinical settings by reducing anatomical dead space and maintaining FiO₂, but its application during anesthesia induction in TBI patients was previously unexplored. What is new THRIVE significantly improves cerebral oxygenation (rScO₂) during anesthesia induction in TBI patients, with higher PaO₂ and lower PaCO₂ compared to conventional mask ventilation, reducing hypoxemia risk (0% vs. 28.12%).THRIVE enhances neurological outcomes, as evidenced by higher Glasgow Outcome Scale (GOS) scores at discharge, suggesting a potential link between improved intraoperative oxygenation and better prognosis.THRIVE does not increase gastric insufflation risk, as confirmed by unchanged cross-sectional area (CSA) measurements, addressing safety concerns about reflux aspiration during high-flow nasal oxygenation. THRIVE significantly improves cerebral oxygenation (rScO₂) during anesthesia induction in TBI patients, with higher PaO₂ and lower PaCO₂ compared to conventional mask ventilation, reducing hypoxemia risk (0% vs. 28.12%). THRIVE significantly improves cerebral oxygenation (rScO₂) during anesthesia induction in TBI patients, with higher PaO₂ and lower PaCO₂ compared to conventional mask ventilation, reducing hypoxemia risk (0% vs. 28.12%). THRIVE enhances neurological outcomes, as evidenced by higher Glasgow Outcome Scale (GOS) scores at discharge, suggesting a potential link between improved intraoperative oxygenation and better prognosis. THRIVE enhances neurological outcomes, as evidenced by higher Glasgow Outcome Scale (GOS) scores at discharge, suggesting a potential link between improved intraoperative oxygenation and better prognosis. THRIVE does not increase gastric insufflation risk, as confirmed by unchanged cross-sectional area (CSA) measurements, addressing safety concerns about reflux aspiration during high-flow nasal oxygenation. THRIVE does not increase gastric insufflation risk, as confirmed by unchanged cross-sectional area (CSA) measurements, addressing safety concerns about reflux aspiration during high-flow nasal oxygenation.